The upregulation of several stemness markers (e.g., EPCAM, ITGA6, CD133 and CD44) in the EGI1 cell line, which simultaneously shows increased FAO, supports this hypothesis in the context of CCA. The gene discussed is PROM1; the disease is cholangiocarcinoma.